Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Buy
57
EMR Quote, Financials, Valuation and Earnings
Last price:
$123.32
Seasonality move
:
2.75%
Day range:
$121.09 - $124.76
52-week range:
$91.65 - $134.85
Dividend yield:
1.69%
P/E ratio:
36.28x
P/S ratio:
4.07x
P/B ratio:
3.27x
Volume:
9.4M
Avg. volume:
3.2M
1-year change:
31.09%
Market cap:
$70.8B
Revenue:
$17.5B
EPS (TTM):
$3.42
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $16.8B | $12.9B | $13.8B | $15.2B | $17.5B | |
| Revenue Growth (YoY) | -8.64% | -22.96% | 6.74% | 9.86% | 15.35% | |
| Cost of Revenues | $9.8B | $7.2B | $7.5B | $7.7B | $8.6B | |
| Gross Profit | $7B | $5.7B | $6.3B | $7.4B | $8.9B | |
| Gross Profit Margin | 41.76% | 44.31% | 45.68% | 48.98% | 50.8% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $4B | $3.5B | $3.6B | $4.2B | $5.1B | |
| Other Inc / (Exp) | -$293M | -$42M | $270M | $137M | -$557M | |
| Operating Expenses | $4.2B | $3.8B | $4B | $4.7B | $6.2B | |
| Operating Income | $2.8B | $2B | $2.4B | $2.8B | $2.7B | |
| Net Interest Expenses | $156M | $155M | $194M | -- | $89M | |
| EBT. Incl. Unusual Items | $2.3B | $1.8B | $2.4B | $2.9B | $2B | |
| Earnings of Discontinued Ops. | -- | $911M | $1.3B | $10.9B | $350M | |
| Income Tax Expense | $345M | $346M | $549M | $642M | $415M | |
| Net Income to Company | $2B | $1.4B | $1.9B | $2.3B | $1.6B | |
| Minority Interest in Earnings | -$25M | -$24M | $1M | $19M | $13M | |
| Net Income to Common Excl Extra Items | $2B | $2.3B | $3.2B | $13.2B | $2B | |
| Basic EPS (Cont. Ops) | $3.26 | $3.85 | $5.44 | $23.00 | $3.44 | |
| Diluted EPS (Cont. Ops) | $3.24 | $3.82 | $5.41 | $22.88 | $3.43 | |
| Weighted Average Basic Share | $602.9M | $598.1M | $592.9M | $574.2M | $571.3M | |
| Weighted Average Diluted Share | $606.6M | $601.8M | $596.3M | $577.3M | $574M | |
| EBITDA | $3.4B | $2.7B | $3.5B | $4.2B | $4B | |
| EBIT | $2.5B | $1.9B | $2.7B | $3.2B | $2.3B | |
| Revenue (Reported) | $16.8B | $12.9B | $13.8B | $15.2B | $17.5B | |
| Operating Income (Reported) | $2.8B | $2B | $2.4B | $2.8B | $2.7B | |
| Operating Income (Adjusted) | $2.5B | $1.9B | $2.7B | $3.2B | $2.3B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $4.6B | -$357M | $3.9B | $4.1B | $4.6B | |
| Revenue Growth (YoY) | -8.31% | -- | -- | 5.09% | 12.93% | |
| Cost of Revenues | $2.7B | -$520M | $2.1B | $2.1B | $2.2B | |
| Gross Profit | $1.9B | $163M | $1.8B | $2B | $2.4B | |
| Gross Profit Margin | 41.29% | -45.66% | 46.99% | 49.19% | 51.33% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $933M | $369M | $983M | $1.1B | $1.3B | |
| Other Inc / (Exp) | -$77M | -$22M | -$60M | $139M | -$93M | |
| Operating Expenses | $1B | $423M | $1.1B | $1.2B | $1.6B | |
| Operating Income | $882M | -$260M | $717M | $773M | $790M | |
| Net Interest Expenses | $40M | $40M | $54M | -- | $18M | |
| EBT. Incl. Unusual Items | $765M | -$322M | $603M | $1B | $679M | |
| Earnings of Discontinued Ops. | -- | -- | $255M | -$40M | $438M | |
| Income Tax Expense | $35M | -$85M | $150M | $242M | $149M | |
| Net Income to Company | $730M | -$237M | $453M | $778M | $530M | |
| Minority Interest in Earnings | -$7M | -$4M | $32M | $6M | $28M | |
| Net Income to Common Excl Extra Items | $723M | $670M | $740M | $744M | $996M | |
| Basic EPS (Cont. Ops) | $1.21 | $1.12 | $1.24 | $1.30 | $1.75 | |
| Diluted EPS (Cont. Ops) | $1.20 | $1.11 | $1.24 | $1.29 | $1.73 | |
| Weighted Average Basic Share | $597.2M | $596.3M | $590.8M | $571.5M | $571M | |
| Weighted Average Diluted Share | $601.2M | $600.3M | $594.5M | $574.9M | $573.7M | |
| EBITDA | $1B | -$218M | $944M | $1.4B | $1.3B | |
| EBIT | $808M | -$272M | $673M | $1.2B | $845M | |
| Revenue (Reported) | $4.6B | -$357M | $3.9B | $4.1B | $4.6B | |
| Operating Income (Reported) | $882M | -$260M | $717M | $773M | $790M | |
| Operating Income (Adjusted) | $808M | -$272M | $673M | $1.2B | $845M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $16.8B | $12.9B | $13.8B | $15.2B | $17.5B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $9.8B | $7.2B | $7.5B | $7.7B | $8.6B | |
| Gross Profit | $7B | $5.7B | $6.3B | $7.4B | $8.9B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $4B | $3.5B | $3.6B | $4.2B | $5.1B | |
| Other Inc / (Exp) | -$302M | -$42M | $244M | $137M | -$652M | |
| Operating Expenses | $4.2B | $3.8B | $3.9B | $4.7B | $6.2B | |
| Operating Income | $2.8B | $2B | $2.4B | $2.8B | $2.7B | |
| Net Interest Expenses | $156M | $155M | $194M | -- | $89M | |
| EBT. Incl. Unusual Items | $2.3B | $1.8B | $2.4B | $2.9B | $1.9B | |
| Earnings of Discontinued Ops. | -- | -- | $1.3B | $10.9B | $423M | |
| Income Tax Expense | $345M | $346M | $549M | $642M | $393M | |
| Net Income to Company | $2B | $1.4B | $1.9B | $2.3B | $1.6B | |
| Minority Interest in Earnings | -$25M | -$24M | $1M | $19M | $13M | |
| Net Income to Common Excl Extra Items | $2B | $2.3B | $3.2B | $13.2B | $2B | |
| Basic EPS (Cont. Ops) | $3.26 | $3.85 | $5.44 | $23.04 | $3.45 | |
| Diluted EPS (Cont. Ops) | $3.24 | $3.82 | $5.41 | $22.92 | $3.42 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | $3.4B | $2.7B | $3.5B | $4.3B | $4B | |
| EBIT | $2.5B | $1.9B | $2.7B | $3.2B | $2.3B | |
| Revenue (Reported) | $16.8B | $12.9B | $13.8B | $15.2B | $17.5B | |
| Operating Income (Reported) | $2.8B | $2B | $2.4B | $2.8B | $2.7B | |
| Operating Income (Adjusted) | $2.5B | $1.9B | $2.7B | $3.2B | $2.3B | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $12.9B | $13.8B | $15.2B | $17.5B | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $7.2B | $7.5B | $7.7B | $8.6B | -- | |
| Gross Profit | $5.7B | $6.3B | $7.4B | $8.9B | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $3.5B | $3.6B | $4.2B | $5.1B | -- | |
| Other Inc / (Exp) | -$42M | $244M | $137M | -$652M | -- | |
| Operating Expenses | $3.8B | $3.9B | $4.7B | $6.2B | -- | |
| Operating Income | $2B | $2.4B | $2.8B | $2.7B | -- | |
| Net Interest Expenses | $155M | $194M | $101M | $89M | -- | |
| EBT. Incl. Unusual Items | $1.8B | $2.4B | $2.9B | $1.9B | -- | |
| Earnings of Discontinued Ops. | -- | $1.3B | $10.9B | $423M | -- | |
| Income Tax Expense | $346M | $549M | $642M | $393M | -- | |
| Net Income to Company | $1.4B | $1.9B | $2.3B | $1.6B | -- | |
| Minority Interest in Earnings | -$24M | $1M | $19M | $13M | -- | |
| Net Income to Common Excl Extra Items | $2.3B | $3.2B | $13.2B | $2B | -- | |
| Basic EPS (Cont. Ops) | $3.85 | $5.44 | $23.04 | $3.45 | -- | |
| Diluted EPS (Cont. Ops) | $3.82 | $5.41 | $22.92 | $3.42 | -- | |
| Weighted Average Basic Share | $2.4B | $2.4B | $2.3B | $2.3B | -- | |
| Weighted Average Diluted Share | $2.4B | $2.4B | $2.3B | $2.3B | -- | |
| EBITDA | $2.7B | $3.5B | $4.3B | $4B | -- | |
| EBIT | $1.9B | $2.7B | $3.2B | $2.3B | -- | |
| Revenue (Reported) | $12.9B | $13.8B | $15.2B | $17.5B | -- | |
| Operating Income (Reported) | $2B | $2.4B | $2.8B | $2.7B | -- | |
| Operating Income (Adjusted) | $1.9B | $2.7B | $3.2B | $2.3B | -- | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $3.3B | $2.4B | $1.8B | $8.1B | $3.6B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $2.8B | $3B | $2.3B | $2.5B | $2.9B | |
| Inventory | $1.9B | $2.1B | $1.7B | $2B | $2.2B | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $761M | $1.1B | $1.3B | $1.2B | $1.5B | |
| Total Current Assets | $8.8B | $8.4B | $8.5B | $13.8B | $10.2B | |
| Property Plant And Equipment | $3.7B | $3.7B | $2.2B | $2.4B | $2.8B | |
| Long-Term Investments | -- | -- | -- | $3.3B | -- | |
| Goodwill | $6.7B | $7.7B | $13.9B | $14.5B | $18.1B | |
| Other Intangibles | $2.5B | $2.9B | $6.6B | $6.3B | $10.4B | |
| Other Long-Term Assets | $1.2B | $1.9B | $4.4B | $2.6B | $2.7B | |
| Total Assets | $22.9B | $24.7B | $35.7B | $42.7B | $44.2B | |
| Accounts Payable | $1.7B | $2.1B | $1.3B | $1.3B | $1.3B | |
| Accrued Expenses | $2.9B | $3.3B | $3B | $3.2B | $3.9B | |
| Current Portion Of Long-Term Debt | $322M | $538M | $516M | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | $1.3B | -- | -- | |
| Total Current Liabilities | $5.8B | $6.2B | $7.8B | $5B | $5.7B | |
| Long-Term Debt | $6.3B | $5.8B | $8.3B | $7.6B | $7.2B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $14.4B | $14.8B | $19.4B | $16.1B | $16.7B | |
| Common Stock | $477M | $477M | $477M | $477M | $477M | |
| Other Common Equity Adj | -- | -- | -$1.5B | -$1.3B | -$868M | |
| Common Equity | $8.4B | $9.9B | $10.4B | $20.7B | $21.6B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $42M | $40M | $6B | $5.9B | $5.9B | |
| Total Equity | $8.4B | $9.9B | $16.3B | $26.6B | $27.5B | |
| Total Liabilities and Equity | $22.9B | $24.7B | $35.7B | $42.7B | $44.2B | |
| Cash and Short Terms | $3.3B | $2.4B | $1.8B | $8.1B | $3.6B | |
| Total Debt | $7.5B | $6.7B | $10.4B | $8.2B | $7.7B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $3.3B | $2.4B | $1.8B | $8.1B | $3.6B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $2.8B | $3B | $2.3B | $2.5B | $2.9B | |
| Inventory | $1.9B | $2.1B | $1.7B | $2B | $2.2B | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $761M | $1.1B | $1.3B | $1.2B | $1.5B | |
| Total Current Assets | $8.8B | $8.4B | $8.5B | $13.8B | $10.2B | |
| Property Plant And Equipment | $3.7B | $3.7B | $2.2B | $2.4B | $2.8B | |
| Long-Term Investments | -- | -- | -- | $3.3B | -- | |
| Goodwill | $6.7B | $7.7B | $13.9B | $14.5B | $18.1B | |
| Other Intangibles | $2.5B | $2.9B | $6.6B | $6.3B | $10.4B | |
| Other Long-Term Assets | $1.2B | $1.9B | $4.4B | $2.6B | $2.7B | |
| Total Assets | $22.9B | $24.7B | $35.7B | $42.7B | $44.2B | |
| Accounts Payable | $1.7B | $2.1B | $1.3B | $1.3B | $1.3B | |
| Accrued Expenses | $2.9B | $3.3B | $3B | $3.2B | $3.9B | |
| Current Portion Of Long-Term Debt | $322M | $538M | $516M | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | $1.3B | -- | -- | |
| Total Current Liabilities | $5.8B | $6.2B | $7.8B | $5B | $5.7B | |
| Long-Term Debt | $6.3B | $5.8B | $8.3B | $7.6B | $7.2B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $14.4B | $14.8B | $19.4B | $16.1B | $16.7B | |
| Common Stock | $477M | $477M | $477M | $477M | $477M | |
| Other Common Equity Adj | -- | -- | -$1.5B | -$1.3B | -$868M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $42M | $40M | $6B | $5.9B | $5.9B | |
| Total Equity | $8.4B | $9.9B | $16.3B | $26.6B | $27.5B | |
| Total Liabilities and Equity | $22.9B | $24.7B | $35.7B | $42.7B | $44.2B | |
| Cash and Short Terms | $3.3B | $2.4B | $1.8B | $8.1B | $3.6B | |
| Total Debt | $7.5B | $6.7B | $10.4B | $8.2B | $7.7B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $2B | $1.4B | $1.9B | $2.3B | $1.6B | |
| Depreciation & Amoritzation | $854M | $762M | $842M | $1.1B | $1.7B | |
| Stock-Based Compensation | $110M | $197M | $125M | $250M | $260M | |
| Change in Accounts Receivable | $207M | -$18M | -$143M | -$191M | -$99M | |
| Change in Inventories | -$6M | -$11M | -$334M | -$160M | $122M | |
| Cash From Operations | $3.1B | $3.6B | $2.9B | $637M | $3.3B | |
| Capital Expenditures | $538M | $404M | $299M | $363M | $419M | |
| Cash Acquisitions | -$126M | -$1.6B | -$5.7B | -$705M | -$8.3B | |
| Cash From Investing | -$740M | -$2.1B | -$5.3B | $12.4B | -$5.4B | |
| Dividends Paid (Ex Special Dividend) | -$1.2B | -$1.2B | -$1.2B | -$1.2B | -$1.2B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $3.3B | $71M | $5.4B | $395M | $322M | |
| Long-Term Debt Repaid | -$1.6B | -$883M | -$1.7B | -$3.6B | -$889M | |
| Repurchase of Common Stock | -$942M | -$500M | -$500M | -$2.2B | -$643M | |
| Other Financing Activities | $2M | $100M | $80M | -$169M | -$44M | |
| Cash From Financing | -$509M | -$2.4B | $2B | -$6.8B | -$2.5B | |
| Beginning Cash (CF) | $1.5B | $3.3B | $2.4B | $1.8B | $8.1B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $1.8B | -$967M | -$364M | $6.2B | -$4.5B | |
| Ending Cash (CF) | $3.3B | $2.4B | $1.8B | $8.1B | $3.6B | |
| Levered Free Cash Flow | $2.5B | $3.2B | $2.6B | $274M | $2.9B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $730M | -$237M | $453M | $778M | $530M | |
| Depreciation & Amoritzation | $223M | $42M | $271M | $271M | $426M | |
| Stock-Based Compensation | $41M | $6M | $34M | $52M | $57M | |
| Change in Accounts Receivable | -$249M | -$94M | -$174M | -$77M | -$143M | |
| Change in Inventories | $212M | $149M | $19M | $99M | $156M | |
| Cash From Operations | $1.2B | $855M | $1.2B | -$643M | $1.1B | |
| Capital Expenditures | $209M | $54M | $100M | $169M | $168M | |
| Cash Acquisitions | -$12M | $49M | -$508M | -$720M | -$79M | |
| Cash From Investing | -$232M | -$212M | -$359M | -$685M | $3.2B | |
| Dividends Paid (Ex Special Dividend) | -$299M | -$301M | -$305M | -$298M | -$300M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $973M | -$31M | -$392M | -- | -$2.2B | |
| Long-Term Debt Repaid | -$794M | -$578M | -$730M | -$99M | -$242M | |
| Repurchase of Common Stock | -- | -$232M | -$82M | -$114M | -$280M | |
| Other Financing Activities | -$26M | $11M | -- | -$10M | $13M | |
| Cash From Financing | -$146M | -$1.1B | -$1.5B | -$521M | -$3B | |
| Beginning Cash (CF) | $2.5B | $2.9B | $2.5B | $10B | $2.3B | |
| Foreign Exchange Rate Adjustment | $14M | -$18M | -$74M | -$57M | $40M | |
| Additions / Reductions | $851M | -$488M | -$651M | -$1.8B | $1.3B | |
| Ending Cash (CF) | $3.3B | $2.4B | $1.8B | $8.1B | $3.6B | |
| Levered Free Cash Flow | $1B | $801M | $1.1B | -$812M | $916M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $2B | $1.4B | $1.9B | $2.3B | $1.6B | |
| Depreciation & Amoritzation | $854M | $762M | $842M | $1.1B | $1.7B | |
| Stock-Based Compensation | $110M | $197M | $125M | $250M | $260M | |
| Change in Accounts Receivable | $207M | -$18M | -$143M | -$191M | -$99M | |
| Change in Inventories | -$6M | -$11M | -$334M | -$160M | $122M | |
| Cash From Operations | $3.1B | $3.6B | $2.9B | $637M | $3.3B | |
| Capital Expenditures | $538M | $404M | $299M | $363M | $419M | |
| Cash Acquisitions | -$126M | -$1.6B | -$5.7B | -$705M | -$8.3B | |
| Cash From Investing | -$740M | -$2.1B | -$5.3B | $12.4B | -$5.4B | |
| Dividends Paid (Ex Special Dividend) | -$1.2B | -$1.2B | -$1.2B | -$1.2B | -$1.2B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $3.3B | $71M | $5.4B | -- | -- | |
| Long-Term Debt Repaid | -$1.6B | -$883M | -$1.7B | -$3.6B | -$889M | |
| Repurchase of Common Stock | -$942M | -$500M | -$500M | -$2.2B | -$643M | |
| Other Financing Activities | $2M | $100M | $80M | -$169M | -$44M | |
| Cash From Financing | -$509M | -$2.4B | $2B | -$6.8B | -$2.5B | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $1.8B | -$967M | -$364M | $6.2B | -$4.5B | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $2.5B | $3.2B | $2.6B | $274M | $2.9B | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $1.4B | $1.9B | $2.3B | $1.6B | -- | |
| Depreciation & Amoritzation | $762M | $842M | $1.1B | $1.7B | -- | |
| Stock-Based Compensation | $197M | $125M | $250M | $260M | -- | |
| Change in Accounts Receivable | -$18M | -$143M | -$191M | -$99M | -- | |
| Change in Inventories | -$11M | -$334M | -$160M | $122M | -- | |
| Cash From Operations | $3.6B | $2.9B | $637M | $3.3B | -- | |
| Capital Expenditures | $404M | $299M | $363M | $419M | -- | |
| Cash Acquisitions | -$1.6B | -$5.7B | -$705M | -$8.3B | -- | |
| Cash From Investing | -$2.1B | -$5.3B | $12.4B | -$5.4B | -- | |
| Dividends Paid (Ex Special Dividend) | -$1.2B | -$1.2B | -$1.2B | -$1.2B | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $71M | $5.4B | $395M | $322M | -- | |
| Long-Term Debt Repaid | -$883M | -$1.7B | -$3.6B | -$889M | -- | |
| Repurchase of Common Stock | -$500M | -$500M | -$2.2B | -$643M | -- | |
| Other Financing Activities | $100M | $80M | -$169M | -$44M | -- | |
| Cash From Financing | -$2.4B | $2B | -$6.8B | -$2.5B | -- | |
| Beginning Cash (CF) | $10.7B | $16.5B | $16.1B | $14.7B | -- | |
| Foreign Exchange Rate Adjustment | $6M | -$186M | $18M | $20M | -- | |
| Additions / Reductions | -$967M | -$364M | $6.2B | -$4.5B | -- | |
| Ending Cash (CF) | $9.8B | $16B | $22.3B | $10.3B | -- | |
| Levered Free Cash Flow | $3.2B | $2.6B | $274M | $2.9B | -- | |
Get EMR Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
EMR
Sector
P/E ratio
36.28x
17.94x
PEG ratio
0.04x
0.34x
P/B ratio
3.27x
1.76x
Price / LTM sales
4.07x
0.97x
Growth Metrics
EMR
Sector
Revenue growth
12.93%
1.77%
Earnings growth
34.11%
1.67%
Revenue (5-year growth)
-0.98%
4.31%
Earnings forecast
$1.47
$0.46
Profitability
EMR
Sector
Profitability FY 2024
$8.9B
$434.2M
Return on invested capital
5.42%
5.93%
Return on assets
4.36%
3.69%
Return on equity
7.34%
8.87%
Earnings Date
Last Earnings Date
Nov
5
Next Earnings Date
Feb
7
Estimated Next Earnings Date
Feb
4
Balance Sheet
EMR
Sector
Total cash
$3.6B
$170.4M
Short term investments
--
$46.5M
Total assets
$44.2B
$2.1B
Long term debt
$7.7B
$147.8M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 23
Quantum [QMCO] is down 0.92% over the past day.
Sell
46
NUKK alert for Dec 23
Nukkleus [NUKK] is up 7.95% over the past day.
Sell
1
IIPR alert for Dec 23
Innovative Industrial Properties [IIPR] is down 5.91% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
